MeScreen Test Reveals If Your Supplements and Ice Baths Are Actually Working
New mitochondrial testing technology helps optimize your health interventions based on cellular function data.
Summary
This episode explores MeScreen, a revolutionary at-home test that measures mitochondrial health and cellular function to determine if your current health interventions are actually working. Host Ben Greenfield interviews Sean Fetcho, CEO of Versea Health, and Dr. Luis Fandos, an interventional pain specialist, about how this technology can reveal whether you're taking too many supplements, overdoing cold therapy, or following the wrong diet for your body. The test provides personalized data on cellular energy production, helping users optimize their health protocols based on actual mitochondrial performance rather than guesswork. This represents a significant shift toward precision health optimization.
Detailed Summary
This episode addresses a critical question for health optimizers: how do you know if your interventions are actually working? Ben Greenfield explores MeScreen technology with CEO Sean Fetcho and Dr. Luis Fandos, revealing how mitochondrial testing can transform personalized health strategies.
The discussion centers on MeScreen's ability to measure cellular energy production and mitochondrial efficiency at home. Unlike traditional biomarkers, this test directly assesses how well your cells generate ATP, providing concrete data on whether supplements, cold exposure, dietary changes, or other interventions are enhancing or hindering cellular function.
Key insights include how over-supplementation can actually impair mitochondrial performance, why some people respond differently to cold therapy, and how dietary approaches affect cellular energy production. The guests explain how genetic variations influence supplement metabolism and why personalized protocols based on mitochondrial data outperform one-size-fits-all approaches.
Dr. Fandos shares clinical applications, demonstrating how mitochondrial testing guides treatment decisions in pain management and functional medicine. The technology helps identify optimal dosing, timing, and combinations of interventions while avoiding potentially harmful over-treatment.
Actionable takeaways include specific protocols for testing intervention effectiveness, guidelines for supplement optimization, and strategies for personalizing cold therapy and dietary approaches. The episode emphasizes moving beyond symptom-based adjustments toward data-driven health optimization, though listeners should consider this emerging technology alongside established health markers and professional guidance.
Key Findings
- MeScreen test measures mitochondrial ATP production to assess if health interventions are working
- Over-supplementation can impair cellular energy production despite good intentions
- Individual genetic variations determine optimal supplement dosing and cold therapy protocols
- Mitochondrial testing reveals personalized dietary approaches for cellular optimization
- Data-driven protocols outperform symptom-based health intervention adjustments
Methodology
Interview format podcast featuring Ben Greenfield with Sean Fetcho (CEO of Versea Health) and Dr. Luis Fandos (interventional pain specialist). Follow-up episode to previous MeScreen discussion addressing listener questions.
Study Limitations
Information based on podcast discussion without access to peer-reviewed studies on MeScreen technology. Claims about mitochondrial testing effectiveness should be verified through published research and clinical validation studies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
